CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic

Li-Ling Chang1, Pin-Nan Cheng, Jiann-Shiuh Chen

  • 1Institute of Molecular Medicine, Medical College, National Cheng Kung University, Tainan 701, Taiwan, ROC.

Antiviral Research
|December 30, 2006
PubMed

Insights

Hepatitis C virus (HCV) treatment outcomes may be linked to CD81 molecule levels. Interferon-alpha therapy down-regulates CD81 expression, particularly in B-cells, indicating a host response associated with sustained virological response (SVR).

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • The CD81 molecule influences T-helper responses and may act as a hepatitis C virus (HCV) receptor.
  • CD81's role in anti-HCV treatment efficacy requires further characterization.
  • Interferon-alpha is a key therapeutic agent for HCV infection.

Purpose of the Study:

  • To investigate interferon-alpha-induced alterations in lymphocytic CD81 expression.
  • To compare CD81 levels and interferon-alpha responsiveness between healthy individuals, chronic HCV patients, and patients with sustained virological response (SVR).

Main Methods:

  • Comparative analysis of surface CD81 levels in lymphocytes from different patient groups.
  • In vitro treatment of lymphocytes and Daudi lymphoid cells with interferon-alpha, interferon-beta, and polyI:C.
  • Investigation of the mechanism of CD81 suppression using 2-aminopurine.

Main Results:

  • Healthy subjects and treatment-naïve HCV patients showed comparable baseline CD81 levels.
  • In vitro interferon-alpha suppressed CD81 expression in lymphocytes from both groups.
  • A significant down-regulation of B-cell CD81 was observed only in patients who achieved SVR.
  • Interferons directly decreased CD81 expression in Daudi cells.
  • The interferon-alpha effect on CD81 was partially restored by 2-aminopurine, implicating double-stranded RNA-activated kinase.

Conclusions:

  • CD81 down-regulation is a host response to interferon-alpha therapy.
  • CD81 modulation is an immunophenotype associated with successful anti-HCV treatment (SVR).
  • Interferon-based therapies may directly impact CD81 expression levels.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...